Atorvastatin Calcium Tablet
Product Images NDC 50090-5636

5 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-5636). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (D800d38e 825d 41d4 B833 0e693d0851e0 01)

Image-01 (D800d38e 825d 41d4 B833 0e693d0851e0 01)
Chemical structure of Atorvastatin Calcium with notation indicating it is a hydrate (Ca2+ with 3H2O) forming part of the compound, shown as a structural diagram with atoms and bonds clearly depicted.*
FDA Label Image

Figure 1: Effect Of Atorvastatin Calcium 10 mg/day On Cumulative Incidence Of Non-fatalmyocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (D800d38e 825d 41d4 B833 0e693d0851e0 02)

Figure 1: Effect Of Atorvastatin Calcium 10 mg/day On Cumulative Incidence Of Non-fatalmyocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (D800d38e 825d 41d4 B833 0e693d0851e0 02)
A cumulative incidence graph comparing Atorvastatin and placebo over approximately 3.5 years. The y-axis represents cumulative incidence percentage from 0 to 4, and the x-axis represents time in years from 0 to 3.5. The solid line shows Atorvastatin, and the dashed line shows placebo, with Atorvastatin incidence consistently lower than placebo.*
FDA Label Image

Figure 2: Effect Of Atorvastatin Calcium 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization, Or Stroke) (D800d38e 825d 41d4 B833 0e693d0851e0 03)

Figure 2: Effect Of Atorvastatin Calcium 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization, Or Stroke) (D800d38e 825d 41d4 B833 0e693d0851e0 03)
A line graph showing the cumulative hazard percentage over five years comparing Atorvastatin to placebo. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. The Atorvastatin line remains consistently below the placebo line, indicating a lower hazard rate, with an HR of 0.63 (0.48-0.83) and p-value of 0.001.*
FDA Label Image

Figure 3: Effect Of Atorvastatin Calcium 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (D800d38e 825d 41d4 B833 0e693d0851e0 04)

Figure 3: Effect Of Atorvastatin Calcium 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (D800d38e 825d 41d4 B833 0e693d0851e0 04)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time between Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis shows time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event (up to 0.2%). The graph includes hazard ratio (HR 0.78), confidence interval (0.69-0.89), and p-value (0.0002) indicating statistical comparison between doses.*
FDA Label Image

Label Image (Lbl500905636)

Label Image (Lbl500905636)
Atorvastatin Calcium 10 mg oral tablets in a 30-tablet package, labeled by A-S Medication Solutions. The label includes NDC 50090-5636, storage instructions to keep at 77 degrees Fahrenheit, and dosage information stating each film-coated tablet contains atorvastatin calcium equivalent to 10 mg atorvastatin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.